Dose-modified lenalidomide induces sustained hematological response in patients with intermediate to high risk myelodysplasia

Alhossain A. Khalafallah, Bernadene Fernandopulle, Terry Brain

Abstract


No Abstract Available


Keywords


Intermediate, high-risk MDS; IPSS; lenalidomide; hematological response; dose-modified.

Full Text: PDF HTML

Mediterr J Hematol Infect Dis ISSN 2035-3006

$